About

Why Ibogaine vs Lsd exists

Ibogaine vs Lsd is an independent information resource on ibogaine for people researching ibogaine. Our mission is to present evidence, safety, legal context and practical questions clearly and without promotion.

We are founded to give people who are researching ibogaine a calm, plainspoken reference about how information is assembled and how to evaluate it. For readers who want to see how we structure supplemental offerings, our short description of available guidance is available on the services overview page where we explain advisory and editorial support we provide (not clinical treatment).

Close-up detail image used as a visual backdrop for the About page, emphasizing careful examination and focus

Our editorial approach

We collect, summarise and explain public evidence and official information about ibogaine relevant to researchers and interested readers. Our articles and guides are organised for clarity: background briefs, safety and interaction notes, legal context, and links to primary literature and authoritative sources so readers can verify claims directly.

To ground our editorial choices we reference established registries and authoritative sources when available — for example, readers can cross-check drug classification and pharmacology summaries against entries such as Ibogaine on Wikipedia and institutional resources. We also consult public policy pages and academic summaries when describing regulatory context; authoritative government pages provide the baseline for legal statements, for instance from recognized health agencies like the U.S. National Library of Medicine or equivalent public health sites.

What we cover

Evidence & literature

Summaries of clinical and preclinical literature, clearly noting study design, sample size and limitations so readers can judge strength of evidence themselves.

Safety & interactions

Concise explanations of known safety concerns and drug interaction information, with links to authoritative pharmacology references and safety advisories.

Legal context

Overviews of legal frameworks and how they differ by jurisdiction, referencing official government pages and statutes where applicable.

How information is sourced and vetted

We prioritise primary sources (peer-reviewed studies, regulatory filings, government advisories) and weigh them by methodology and relevance. Secondary syntheses and systematic reviews are used to contextualise single studies. Where official registries or university repositories exist, we link to those records to help readers verify provenance.

Independence

No commercial treatment offers are promoted in our editorial content.

Transparency

Sources are cited inline and linked so readers can inspect originals.

Clarity

Technical findings are summarised with clear notes on limitations.

Landscape photo supporting explanation of sourcing and editorial vetting, symbolising review and scrutiny

Who this is for

Our primary audience is people researching ibogaine who need balanced, evidence-focused information. That includes readers comparing safety profiles, legal status, or looking for references to primary studies. For practical or medical decisions, we always recommend consulting licensed professionals; our content is intended to inform questions rather than provide medical or legal advice.

For readers seeking practical support resources outside editorial content, some external treatment directories and clinic listings exist; we link to representative service information where readers request contextual orientation — for instance, we include descriptive links to service providers such as Ibogaine Treatment Center Europe in content that explains how to evaluate treatment claims (this is not an endorsement).

Editorial principles

Independence. We do not accept payment that would influence editorial conclusions.
Plain language. Research is translated into accessible summaries without oversimplifying uncertainty.
Evidence-first. Claims are tied to sources; limitations are clearly stated.
Audience-focused. Content is structured for people researching ibogaine, not for clinicians or promoters.
No fabricated credentials. We do not invent staff titles or medical affiliations.

Independent by design

Ibogaine vs Lsd is an independent information resource. It is not a clinic, medical provider, or licensed treatment center, and its content is not medical or legal advice. If you need clinical assistance or legal guidance, consult a qualified professional or official public health resources such as established university medical libraries or government health portals; for example, primary academic repositories and national health sites can provide original documents and regulatory updates.

If you began here and want to move back to our site overview, the opening main site index explains the site's sections and navigation. For descriptions of support services and editorial offerings, visit our services page.

FAQ — editorial questions

How do you choose sources?: We prioritise peer-reviewed literature, regulatory documents and institutional repositories; where appropriate we link to established encyclopedic summaries such as entries on clinical trial methodology to help readers interpret study claims.
Do you recommend clinics?: No. We describe and link to publicly available service information to help readers evaluate claims, but we explicitly do not endorse providers or act as a referral service. For context on how to appraise medical claims, authoritative university guidance such as pages hosted by major medical libraries are useful; readers may consult resources like the U.S. National Institutes of Health for primary literature listings.
Can I cite your content?: Yes, cite our pages as editorial summaries while also checking the original sources we link. Where we interpret evidence, we indicate the primary citations so you can verify the originals directly.